Serum S100B and antioxidant enzymes in bipolar patients

Journal of Psychiatric Research

Volumn 41, Issue 6, 2007, Pages 523-529

  Andreazza, Ana Cristina ^a,b   Cassini, Carina ^c   Rosa, Adriane Ribeiro ^b   Leite, Marina Concli ^a   de Almeida, Lucia M V ^a   Nardin, Patrícia ^a   Cunha, Angelo B N ^b   Ceresér, Keila Maria ^b   Santin, Aida ^b   Gottfried, Carmem ^a   Salvador, Mirian ^c   Kapczinski, Flavio ^a,b   Gonçalves, Carlos Alberto ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIVERSITY OF CAXIAS DO SUL   (Brazil)

Author keywords

Bipolar disorder; Catalase; Glutathione peroxidase; Oxidative stress; S100B; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; CARBAMAZEPINE; CATALASE; ENZYME; GLUTATHIONE PEROXIDASE; LITHIUM; PROTEIN S100B; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; VALPROIC ACID;

ADULT; ARTICLE; BIPOLAR DISORDER; CASE CONTROL STUDY; CELL ACTIVITY; CONTROLLED STUDY; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME ACTIVITY; FEMALE; GLIA CELL; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; MENTAL DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; ANTIOXIDANTS; BIPOLAR DISORDER; CASE-CONTROL STUDIES; CATALASE; DEMOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; OXIDATIVE STRESS; S100 PROTEINS; SPECTROPHOTOMETRY; SUPEROXIDE DISMUTASE;

EID: 33846889102     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2006.07.013     Document Type: Article

References (36)

1. Belmaker R.H. Medical progress: bipolar disorder. New England Journal of Medicine 351 (2004) 476-486
2. Chance B., and Machley A.L. Assay of catalases and peroxidases. Methods in Enzymology 2 (1954) 764-775
3. Chuang D.M. Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?. Critical Reviews in Neurobiology 16 (2004) 83-90
4. Dietrich D.E., Hauser U., Peters M., Zhang Y., Wiesmann M., Hasselmann M., et al. Target evaluation processing and serum levels of nerve tissue protein S100B in patients with remitted major depression. Neuroscience Letter 354 (2004) 69-73
5. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. International Journal of Biochemistry and Cell Biology 33 (2001) 637-668
6. First M.B., Spitzer R.L., Gibbon M., and Williams J.B. Structured clinical interview for DSM-IV (SCID-I) (1998), Biomedics Research Department, New York
7. Floyd R.A. Antioxidants, oxidative stress, and degenerative neurological disorders. Proceedings of the Society for Experimental Biology and Medicine 222 (1999) 236-245
8. Ghribi O., Herman M.M., and Savory J. Lithium inhibits Abeta-induced stress in endoplasmic reticulum of rabbit hippocampus but does not prevent oxidative damage and tau phosphorylation. Journal of Neuroscience Research 71 (2003) 853-862
9. Hamilton M. A rating scale for depression. Journal of Neurology Neurosurgery and Psychiatry 23 (1960) 56-62
10. Hetzel G., Moeller O., Evers S., Erfurth A., Ponath G., Arolt V., et al. The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment. Psychopharmacology 178 (2005) 161-166
11. Johnson F., and Giulivi C. Superoxide dismutases and their impact upon human health. Molecular Aspects of Medicine 26 (2005) 340-352
12. Johnston-Wilson N.L., Sims C.D., Hofmann J.P., Anderson L., Shore A.D., Torrey E.F., et al. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Molecular Psychiatry 5 (2000) 142-149
13. Kuloglu M., Ustundag B., Atmaca M., Canatan H., Tezcan E., and Cinkilinc N. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar desorder. Cell Biochemistry and Function 20 (2002) 171-175
14. Kupfer D.J. The increasing medical burden in bipolar disorder. Journal of the American Medical Association 293 (2005) 2528-2530
15. Lai J.S., Zhao C., Warsh J.J., and Li P.P. Cytoprotection by lithium and valproate varies between cell types and cellular stresses. European Journal of Pharmacology 539 (2006) 18-26
16. Lara D.R., Gama C.S., Belmonte-de-Abreu P., Portela L.V., Goncalves C.A., Fonseca M., et al. Increased serum S100B protein in schizophrenia: a study in medication-free patients. Journal of Psychiatry Research 35 (2001) 11-14
17. Machado-Vieira R. Avaliação neuroqui{dotless}́mica de alterações tróficas e/ou dano neurônio - glial durante episódios mani{dotless}́acos. PhD Thesis. University of São Paulo; 2005.
18. Machado-Vieira R., Lara D.R., Portela L.V., Goncalves C.A., Soares J.C., Kapczinski F., et al. Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study. European Neuropsychopharmacology 12 (2002) 269-272
19. Mirsa H.P., and Fridovich I. The role of superoxide anion in the antioxidation of epinephrine and a simple assay for superoxide dismutase. Journal of Biological Chemistry 217 (1972) 3170-3175
20. Murray C.J., and Lopez A.D. The utility of DALYs for public health policy and research: a reply. Bulletin of the World Health Organization 75 (1997) 377-381
21. Netto C.B., Portela L.V., Ferreira C.T., Kieling C., Matte U., Felix T., et al. Ontogenetic changes in serum S100B in Down syndrome patients. Clinical Biochemistry 38 (2005) 433-435
22. Ongur D., Drevets W.C., and Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 13290-13295
23. Ozcan M.E., Gulec M., Ozerol E., Polat R., and Akyol O. Antioxidant enzyme activities and oxidative stress in affective disorders. International Clinical Psychopharmacology 19 (2004) 89-95
24. Ranjekar P.K., Hinge A., Hegde M.V., Ghate M., Kale A., Sitasawad S., et al. Decrease dantioxidant enzymes and membrane essential polyunsaturatiod fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Research 121 (2003) 109-122
25. Rothermundt M., Arolt V., Wiesmann M., Missler U., Peters M., Rudolf S., et al. S-100B is increased in melancholic but not in non-melancholic major depression. Journal of Affective Disorders 66 (2001) 89-93
26. Rothermundt M., Peters M., Prehn J.H., and Arolt V. S100B in brain damage and neurodegeneration. Microscopy Research and Technique 60 (2003) 614-632
27. Savas H.A., Gergerlioglu H.S., Armutcu F., Herken H., Yilmaz H.R., Kocoglu E., et al. Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes. World Journal of Biological Psychiatry 1 (2006) 51-55
28. Schroeter M.L., Abdul-Khaliq H., Diefenbacher A., and Blasig I.E. S100B is increased in mood disorders and may be reduced by antidepressive treatment. Neuroreport 13 (2002) 1675-1678
29. Shao L., Young L.T., and Wang J.F. Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Biological Psychiatry 58 11 (2005) 879-884
30. Takuma K., Baba A., and Matsuda T. Astrocyte apoptosis: implications for neuroprotection. Progress in Neurobiology 72 (2004) 111-127
31. Tramontina F., Karl J., Gottfried C., Mendez A., Goncalves D., Portela L.V., and Goncalves C.A. Digitonin-permeabilization of astrocytes in culture monitored by trypan blue exclusion and loss of S100B by ELISA. Brain Research Protocols 6 (2000) 86-90
32. Van Eldik L.J., and Wainwright M.S. The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restorative Neurology and Neuroscience 21 (2003) 97-108
33. Wendel A. Glutathione peroxidase. Methods in Enzymology 77 (1981) 325-333
34. Wiesmann M., Wandinger K.P., Missler U., Eckhoff D., Rothermundt M., and Arolt Kirchner H. Elevated plasma levels of S-100b protein in schizophrenic patients. Biological Psychiatry 45 (1999) 1508-1511
35. Wills E.D. Mechanism of lipid peroxide formation in animal tissues. Biochemical Journal 99 (1966) 667-676
36. Young R.C., Biggs J.T., Ziegler V.E., and Meyer D.A. A rating scale for mania: reliability, validity, and sensitivity. British Journal of Psychiatry 133 (1978) 429-435